Infectious Disease Doctors in Fort Belvoir, VA Accepting Medicare
4 Infectious Disease doctors found. Showing 1 - 4
 Dr. Robert Napoleon Wood-morris, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir Community Hospital, Fort Belvoir, VA 22060 Phone: 571-231-1402 |
Dr. Paul Michael Robben, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: Fort Belvoir Community Hospital, 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-1402 |
 Lauren Cameron Fiske, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-1402 |
Dr. George Winston Christopher, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 8725 John J Kingman Rd, Stop 6201, Fort Belvoir, VA 22060 Phone: 703-767-2347 |
News Archive
Restricting antibiotics use unlikely to stop spread of drug resistance in typhoid fever
Restricting the use of antibiotics is unlikely to stop the spread of drug resistance in typhoid fever, according to a study funded by the Wellcome Trust and published in the journal eLife.
Consuming less sodium not linked to lower blood pressure, study finds
A new study that followed more than 2,600 men and women for 16 years found that consuming less sodium wasn't associated with lower blood pressure. The new findings call into question the sodium limits recommended by the current Dietary Guidelines for Americans.
New campaign offers information and resources on seasonal and H1N1 flu prevention
Blue Cross Blue Shield of Arizona (BCBSAZ) says "Get the facts, not the flu," in a new campaign that launches today at azblue.com/Flu. The flu campaign offers its members, employer groups and Arizona residents information and resources on seasonal and H1N1 flu prevention and immunization.
Concert initiates CTP-499 Phase 1 study in patients with diabetic nephropathy
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development.
› Verified 8 days ago
Family Medicine
Internal Medicine
General Practice
Psychiatry & Neurology
Emergency Medicine
Preventive Medicine
Anesthesiology
Orthopaedic Surgery
Surgery
Radiology
Pediatrics